A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of OCV-C02 in Patients With Advanced or Relapsed
Colorectal Cancer Who Are Refractory or Intolerant to Standard Chemotherapy